Stryker Corporation (SYK) Earnings Per Share (EPS): 8.64
Is Stryker Corporation’s earnings per share (EPS) high or low?
Stryker Corporation's earnings per share (EPS) of 8.64 is 28% above its 5-year average of 6.75, near the high end of its 5-year range (4.26–8.64).
As of Wednesday, June 17, 2026. 5.69% above its 12-month average of 8.18.
SYK Earnings Per Share (EPS) Chart
SYK Average Earnings Per Share (EPS) Chart
SYK Current vs Average Earnings Per Share (EPS) Chart
SYK Earnings Per Share (EPS) Metrics
EARNINGS PER SHARE (EPS)
8.64
EARNINGS PER SHARE (EPS) AVG TTM
8.18
EARNINGS PER SHARE (EPS) AVG 3Y
7.73
EARNINGS PER SHARE (EPS) AVG 5Y
6.75
EARNINGS PER SHARE (EPS) AVG 10Y
6.04
EARNINGS PER SHARE (EPS) AVG 15Y
5.04
EARNINGS PER SHARE (EPS) AVG 20Y
4.39
CURRENT VS TTM AVG
+5.69%
CURRENT VS 3Y AVG
+11.77%
CURRENT VS 5Y AVG
+28.09%
CURRENT VS 10Y AVG
+42.94%
CURRENT VS 15Y AVG
+71.49%
CURRENT VS 20Y AVG
+96.79%
SYK Competitors' Earnings Per Share (EPS)
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $119.06B | 8.64 | 8.18 | 7.73 | 6.75 |
| Bristol-Myers Squibb Company (BMY)vs › | $114.38B | 3.56 | -0.48 | 1.47 | 0.84 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $113.82B | 16.86 | 6.69 | 10.10 | 9.99 |
| CVS Health Corporation (CVS)vs › | $127.54B | 2.27 | 2.53 | 3.71 | 4.39 |
| Danaher Corporation (DHR)vs › | $128.72B | 5.17 | 5.20 | 6.66 | 6.73 |
| Medtronic plc (MDT)vs › | $104.05B | 3.73 | 3.69 | 3.25 | 3.23 |
| Intuitive Surgical, Inc. (ISRG)vs › | $148.26B | 8.25 | 7.27 | 5.84 | 5.20 |
| Pfizer Inc. (PFE)vs › | $148.76B | 1.31 | 1.39 | 2.19 | 2.39 |
| HCA Healthcare, Inc. (HCA)vs › | $88.05B | 29.08 | 25.45 | 22.39 | 20.36 |
| Elevance Health Inc. (ELV)vs › | $86.74B | 23.51 | 25.49 | 25.23 | 24.07 |
EPS Comparison
Trailing EPS (TTM)
$8.64
Forward EPS (Est.)
$16.73
P/E Ratio
36.0
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
- Directly impacts stock valuation through P/E ratio
- Used to calculate dividend coverage and payout ratios
- Enables comparison across companies of different sizes
- Growth in EPS often correlates with stock price appreciation
Stryker Corporation Earnings Per Share (EPS) Formula & Definition
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Stryker Corporation Earnings Per Share (EPS) FAQ
- What is the earnings per share (EPS) for Stryker Corporation (SYK)?
- The earnings per share (EPS) for SYK stock is 8.64.
- Is Stryker Corporation's earnings per share (EPS) high or low?
- Stryker Corporation's earnings per share (EPS) of 8.64 is 28% above its 5-year average of 6.75, near the high end of its 5-year range (4.26–8.64).
- What is the TTM average earnings per share (EPS) for Stryker Corporation (SYK)?
- The TTM average earnings per share (EPS) for SYK stock is 8.18.
- What is the 3Y average earnings per share (EPS) for Stryker Corporation (SYK)?
- The 3Y average earnings per share (EPS) for SYK stock is 7.73.
- What is the 5Y average earnings per share (EPS) for Stryker Corporation (SYK)?
- The 5Y average earnings per share (EPS) for SYK stock is 6.75.
- What is the 10Y average earnings per share (EPS) for Stryker Corporation (SYK)?
- The 10Y average earnings per share (EPS) for SYK stock is 6.04.
- What is the 15Y average earnings per share (EPS) for Stryker Corporation (SYK)?
- The 15Y average earnings per share (EPS) for SYK stock is 5.04.
- What is the 20Y average earnings per share (EPS) for Stryker Corporation (SYK)?
- The 20Y average earnings per share (EPS) for SYK stock is 4.39.
Stryker Corporation Earnings Per Share (EPS) History
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 8.49 |
| 2024-12-31 | 7.86 |
| 2023-12-31 | 8.34 |
| 2022-12-31 | 6.23 |
| 2021-12-31 | 5.29 |
| 2020-12-31 | 4.26 |
| 2019-12-31 | 5.57 |
| 2018-12-31 | 9.50 |
| 2017-12-31 | 2.73 |
| 2016-12-31 | 4.40 |
| 2015-12-31 | 3.82 |
| 2014-12-31 | 1.36 |
| 2013-12-31 | 2.66 |
| 2012-12-31 | 3.41 |
| 2011-12-31 | 3.48 |
| 2010-12-31 | 3.21 |
| 2009-12-31 | 2.79 |
| 2008-12-31 | 2.81 |
| 2007-12-31 | 2.48 |
| 2006-12-31 | 1.91 |
| 2005-12-31 | 1.60 |
| 2004-12-31 | 1.10 |
| 2003-12-31 | 1.09 |
| 2002-12-31 | 0.83 |
| 2001-12-31 | 0.69 |
| 2000-12-31 | 0.56 |
| 1999-12-31 | 0.05 |
| 1998-12-31 | 0.16 |
| 1997-12-31 | 0.33 |
| 1996-12-31 | 0.27 |
Related Metrics
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo